These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38044089)

  • 1. Innovative System for Delivering Nucleic Acids/Genes Based on Controlled Intracellular Trafficking as Well as Controlled Biodistribution for Nanomedicines.
    Harashima H
    Biol Pharm Bull; 2023; 46(12):1648-1660. PubMed ID: 38044089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.
    Yamada Y; Sato Y; Nakamura T; Harashima H
    J Control Release; 2020 Nov; 327():533-545. PubMed ID: 32916227
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
    Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
    M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.
    Sato Y; Sakurai Y; Kajimoto K; Nakamura T; Yamada Y; Akita H; Harashima H
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27797146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based nucleic acid therapeutics with in vivo efficacy.
    Sufian MA; Ilies MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Nanomedicine: Delivery Strategies and Applications.
    Byun J; Wu Y; Park J; Kim JS; Li Q; Choi J; Shin N; Lan M; Cai Y; Lee J; Oh YK
    AAPS J; 2023 Oct; 25(6):95. PubMed ID: 37784005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.
    Kajimoto K; Sato Y; Nakamura T; Yamada Y; Harashima H
    J Control Release; 2014 Sep; 190():593-606. PubMed ID: 24794902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydrophobic tails of plier-like cationic lipids on nucleic acid delivery and intracellular trafficking.
    Pengnam S; Plainwong S; Patrojanasophon P; Rojanarata T; Ngawhirunpat T; Radchatawedchakoon W; Niyomtham N; Yingyongnarongkul BE; Opanasopit P
    Int J Pharm; 2020 Jan; 573():118798. PubMed ID: 31759106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in nanoparticle-mediated siRNA delivery.
    Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
    Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a multifunctional envelope-type nano device and its application to nanomedicine.
    Sato Y; Nakamura T; Yamada Y; Harashima H
    J Control Release; 2016 Dec; 244(Pt B):194-204. PubMed ID: 27374187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines.
    Nakamura T; Sato Y; Yamada Y; Abd Elwakil MM; Kimura S; Younis MA; Harashima H
    Adv Drug Deliv Rev; 2022 Sep; 188():114417. PubMed ID: 35787389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of tissue-selective gene delivery by lipid nanoparticles.
    Kimura S; Harashima H
    J Control Release; 2023 Oct; 362():797-811. PubMed ID: 37004796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA.
    Habrant D; Peuziat P; Colombani T; Dallet L; Gehin J; Goudeau E; Evrard B; Lambert O; Haudebourg T; Pitard B
    J Med Chem; 2016 Apr; 59(7):3046-62. PubMed ID: 26943260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA.
    Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Pozo-Rodríguez AD; Solinís Aspiazu MÁ
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
    Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H
    Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.
    Park J; Park J; Pei Y; Xu J; Yeo Y
    Adv Drug Deliv Rev; 2016 Sep; 104():93-109. PubMed ID: 26686832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.